As of January 23, 2025, Virax Biolabs (VRAX) has a market cap of $9.292 million USD. According to our data, Virax Biolabs is ranked No.8896 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $9.29 M |
-4.89%
|
Dec 31, 2024 | $9.77 M |
54.11%
|
Dec 29, 2023 | $6.34 M |
-80.00%
|
Dec 30, 2022 | $31.70 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
Agilent Technologies
A
|
$43.58 B |
0.000 M
|
USA
|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Qiagen
QGEN
|
$10.50 B |
0.000 M
|
Netherlands
|
Danaher
DHR
|
$176.37 B |
0.003 M
|
USA
|
Becton Dickinson
BDX
|
$69.00 B |
-0.002 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Abbott Laboratories
ABT
|
$204.28 B |
0.006 M
|
USA
|
Hologic
HOLX
|
$16.07 B |
-0.000 M
|
USA
|
Charles River Laboratories
CRL
|
$8.60 B |
-0.000 M
|
USA
|
Bio-Techne
TECH
|
$12.51 B |
0.000 M
|
USA
|
Market Cap | = | VRAX Stock Price | * | VRAX Shares Outstanding |
= | $2.14 | * | 4.34 M | |
= | $9.29 M |